Revenue | ₹99.53Cr |
Net Profits | ₹31.99Cr |
Net Profit Margins | 32.14% |
Jagsonpal Pharmaceuticals Ltd’s revenue jumped 100.02% since last year same period to ₹99.53Cr in the Q3 2024-2025. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated 30.36% jump in its revenue since last 3-months.
Jagsonpal Pharmaceuticals Ltd’s net profit jumped 707.83% since last year same period to ₹31.99Cr in the Q3 2024-2025. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated 179.14% jump in its net profits since last 3-months.
Jagsonpal Pharmaceuticals Ltd’s net profit margin jumped 303.87% since last year same period to 32.14% in the Q3 2024-2025. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated 114.13% jump in its net profit margins since last 3-months.
The revenue for Jagsonpal Pharmaceuticals Ltd in the Q3 results 2024 was ₹99.53Cr.
The net profit for Jagsonpal Pharmaceuticals Ltd in the Q3 results 2024 was ₹31.99Cr.
The net profit margin for Jagsonpal Pharmaceuticals Ltd in the Q3 results 2024 was 32.14%.
The revenue for Jagsonpal Pharmaceuticals Ltd in the Q3 results 2023 was ₹49.76Cr.
The net profit for Jagsonpal Pharmaceuticals Ltd in the Q3 results 2023 was ₹3.96Cr.
The net profit margin for Jagsonpal Pharmaceuticals Ltd in the Q3 results 2023 was 7.96%.